Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT05955521
NA
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
Sponsor: Samsung Medical Center
View on ClinicalTrials.gov
Summary
This study is the experimental study for serial ctDNA and exosome evaluation in EBC patients
Official title: Development of a Prognostic and Predictive Biomarker for Locally Advanced Breast Cancer Patients Treated With Neoadjuvant Chemotherapy Using Exosome
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
200
Start Date
2021-05-01
Completion Date
2028-07-01
Last Updated
2023-07-21
Healthy Volunteers
Yes
Interventions
PROCEDURE
exosome and ctDNA evaluation
Serial exosome and ctDNA evaluation during follow up period between neoadjuvant chemotherapy and surveillance after curative surgery.
Locations (1)
Ji-Yeon Kim
Seoul, South Korea